COPYRIGHT© Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

COPYRIGHT© 2018  吉林紫鑫药业股份有限公司

Jilin Zixin Pharmaceutical Co., Ltd. Announcement on the Dissolution of Shareholder Equity and Re-Pledge

Page view

Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2013-040

Jilin Zixin Pharmaceutical Co., Ltd.

Announcement on the dissolution of shareholder pledge and re-pledge

The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.

   

On October 11, 2013, the company received the controlling shareholder Dunhua Kangping Investment Co., Ltd. (hereinafter referred to as Kangping Company) Notice: Kangping Company pledges to Jilin Bank Co., Ltd. Changchun Ruixiang Sub-branch on October 15, 2012 (hereinafter referred to as : Jixing Ruixiang Branch) The company's unrestricted tradable shares of 26,000,000 shares (accounting for 5.07% of the company's total share capital) were processed on October 10, 2013 at China Securities Depository and Clearing Co., Ltd. Shenzhen Branch. On the same day, Kangping Company again pledged the above shares to Jixing Ruixiang Sub-branch, and handled the pledge registration formalities at China Securities Depository and Clearing Co., Ltd. Shenzhen Branch. The pledge period began on October 10, 2013 until the pledgee handled the pledge. The date of registration.

 

Kangping Company holds a total of 251,475,016 shares of the company, of which 10,250,000 shares have been engaged in an agreed repurchase transaction. As of the date of this announcement, Kangping Company has plucked 240,430,000 shares of the Company (accounting for 95.61% of the shares held by Kangping Company), accounting for 46.87% of the company's total share capital.

 

Special announcement.

Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors

October 12, 2013